CRESUD S.A.-SPONS ADR (CRESY) Stock Fundamental Analysis

NASDAQ:CRESY • US2264061068

11.66 USD
-0.38 (-3.16%)
At close: Feb 23, 2026
11.66 USD
0 (0%)
After Hours: 2/23/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

CRESY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 88 industry peers in the Food Products industry. CRESY has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, CRESY is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CRESY had positive earnings in 4 of the past 5 years.
  • CRESY had a positive operating cash flow in 4 of the past 5 years.
CRESY Yearly Net Income VS EBIT VS OCF VS FCFCRESY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200B -400B

1.2 Ratios

  • CRESY has a better Return On Assets (3.71%) than 68.18% of its industry peers.
  • CRESY has a better Return On Equity (21.25%) than 93.18% of its industry peers.
  • CRESY has a Return On Invested Capital (2.79%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CRESY is significantly below the industry average of 28.12%.
Industry RankSector Rank
ROA 3.71%
ROE 21.25%
ROIC 2.79%
ROA(3y)2.76%
ROA(5y)1.46%
ROE(3y)14.12%
ROE(5y)0.78%
ROIC(3y)3.01%
ROIC(5y)2.17%
CRESY Yearly ROA, ROE, ROICCRESY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • CRESY's Profit Margin of 22.28% is amongst the best of the industry. CRESY outperforms 97.73% of its industry peers.
  • CRESY's Profit Margin has declined in the last couple of years.
  • The Operating Margin of CRESY (18.19%) is better than 96.59% of its industry peers.
  • In the last couple of years the Operating Margin of CRESY has declined.
  • The Gross Margin of CRESY (40.40%) is better than 90.91% of its industry peers.
  • CRESY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.19%
PM (TTM) 22.28%
GM 40.4%
OM growth 3Y42.09%
OM growth 5Y-1.83%
PM growth 3Y-35.22%
PM growth 5Y-2.22%
GM growth 3Y14.89%
GM growth 5Y2.1%
CRESY Yearly Profit, Operating, Gross MarginsCRESY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60 -80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • The number of shares outstanding for CRESY has been increased compared to 1 year ago.
  • Compared to 5 years ago, CRESY has more shares outstanding
  • CRESY has a worse debt/assets ratio than last year.
CRESY Yearly Shares OutstandingCRESY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CRESY Yearly Total Debt VS Total AssetsCRESY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1T 2T 3T 4T 5T

2.2 Solvency

  • CRESY has a debt to FCF ratio of 17.56. This is a negative value and a sign of low solvency as CRESY would need 17.56 years to pay back of all of its debts.
  • CRESY has a Debt to FCF ratio (17.56) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.33 is on the high side and indicates that CRESY has dependencies on debt financing.
  • CRESY has a worse Debt to Equity ratio (1.33) than 78.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF 17.56
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CRESY Yearly LT Debt VS Equity VS FCFCRESY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B -500B

2.3 Liquidity

  • CRESY has a Current Ratio of 1.43. This is a normal value and indicates that CRESY is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.43, CRESY is in line with its industry, outperforming 46.59% of the companies in the same industry.
  • CRESY has a Quick Ratio of 1.07. This is a normal value and indicates that CRESY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of CRESY (1.07) is better than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.07
CRESY Yearly Current Assets VS Current LiabilitesCRESY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B 800B 1T

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 451.68% over the past year.
  • CRESY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 53.81% yearly.
  • Looking at the last year, CRESY shows a very strong growth in Revenue. The Revenue has grown by 26.52%.
  • Measured over the past years, CRESY shows a very strong growth in Revenue. The Revenue has been growing by 61.88% on average per year.
EPS 1Y (TTM)451.68%
EPS 3Y8.92%
EPS 5Y53.81%
EPS Q2Q%264.2%
Revenue 1Y (TTM)26.52%
Revenue growth 3Y64.16%
Revenue growth 5Y61.88%
Sales Q2Q%48.21%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRESY Yearly Revenue VS EstimatesCRESY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B 800B

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CRESY Price Earnings VS Forward Price EarningsCRESY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRESY Per share dataCRESY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

  • CRESY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CRESY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CRESUD S.A.-SPONS ADR

NASDAQ:CRESY (2/23/2026, 8:00:01 PM)

After market: 11.66 0 (0%)

11.66

-0.38 (-3.16%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-10
Earnings (Next)05-07
Inst Owners5.98%
Inst Owner Change3.85%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap730.51M
Revenue(TTM)1.05T
Net Income(TTM)234.51B
Analysts86.67
Price TargetN/A
Short Float %1.94%
Short Ratio2.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP49.71%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.71%
ROE 21.25%
ROCE 3.68%
ROIC 2.79%
ROICexc 3.24%
ROICexgc 3.26%
OM 18.19%
PM (TTM) 22.28%
GM 40.4%
FCFM 11.08%
ROA(3y)2.76%
ROA(5y)1.46%
ROE(3y)14.12%
ROE(5y)0.78%
ROIC(3y)3.01%
ROIC(5y)2.17%
ROICexc(3y)3.35%
ROICexc(5y)2.42%
ROICexgc(3y)3.42%
ROICexgc(5y)2.47%
ROCE(3y)3.97%
ROCE(5y)2.86%
ROICexgc growth 3Y35.18%
ROICexgc growth 5Y9.08%
ROICexc growth 3Y35.42%
ROICexc growth 5Y10.55%
OM growth 3Y42.09%
OM growth 5Y-1.83%
PM growth 3Y-35.22%
PM growth 5Y-2.22%
GM growth 3Y14.89%
GM growth 5Y2.1%
F-Score6
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF 17.56
Debt/EBITDA 6.95
Cap/Depr 340.81%
Cap/Sales 6.23%
Interest Coverage 1.99
Cash Conversion 86.47%
Profit Quality 49.72%
Current Ratio 1.43
Quick Ratio 1.07
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)583.69%
Cap/Depr(5y)467.81%
Cap/Sales(3y)8.79%
Cap/Sales(5y)7.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)451.68%
EPS 3Y8.92%
EPS 5Y53.81%
EPS Q2Q%264.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.52%
Revenue growth 3Y64.16%
Revenue growth 5Y61.88%
Sales Q2Q%48.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.43%
EBIT growth 3Y133.26%
EBIT growth 5Y58.92%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y152.23%
FCF growth 3Y-26.15%
FCF growth 5Y-36.69%
OCF growth 1Y106.2%
OCF growth 3Y23.9%
OCF growth 5Y-8.1%

CRESUD S.A.-SPONS ADR / CRESY FAQ

What is the fundamental rating for CRESY stock?

ChartMill assigns a fundamental rating of 4 / 10 to CRESY.


Can you provide the valuation status for CRESUD S.A.-SPONS ADR?

ChartMill assigns a valuation rating of 1 / 10 to CRESUD S.A.-SPONS ADR (CRESY). This can be considered as Overvalued.


How profitable is CRESUD S.A.-SPONS ADR (CRESY) stock?

CRESUD S.A.-SPONS ADR (CRESY) has a profitability rating of 6 / 10.


How financially healthy is CRESUD S.A.-SPONS ADR?

The financial health rating of CRESUD S.A.-SPONS ADR (CRESY) is 2 / 10.